Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2007-03-20
2007-03-20
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
C530S351000, C536S023500, C536S024300, C435S320100
Reexamination Certificate
active
10110172
ABSTRACT:
The present invention relates generally to a biologically active complex comprising at least two heterologous molecules. More particularly, the biologically active complex of the present invention comprises at least two polypeptides or parts, fragments, truncates or protease-activated forms of one or more of the polypeptides wherein the complex alone or in association with a receptor, ligand or other molecule facilitates proliferation, differentiation and/or survival of a cell. The identification of the biologically active complex of the present invention permits the assay for agonists and antagonists of the formation of the biologically active complex as well as therapeutic and diagnostic reagents based on the biologically active complex or interaction between the biologically active complex and a receptor, ligand or other molecule.
REFERENCES:
Mikayama et al. Proc. Natl. Acad. Sci. USA vol. 90, pp. 10056-10060, 1993.
Voet et al. Biochemistry. John Wiley & Sons, Inc., pp. 126-128 and 228-234, 1990.
Callard and Gearing (1994), The Cytokine Factsbook, Academic Press Ltd., pp. 39-40.
J. Marmur et al., “Determination of the Base Composition of Deoxyribonucleic Acid from its Thermal Denaturation Temperature”,J. Mol. Biol. 5:109-118 (1962).
W. M. Bonner et al., “A Film Detection Method for Tritium-Labelled Proteins and Nucleic Acids in Polyacrylamide Gels”,Eur. J. Biochem. 46:83-88 (1974).
J. M. Chirgwin et al., “Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease”,Biochemistry 18(24):5294-5299 (1979).
Ausubel et al., “Mapping by Partial Endonuclease Digestions”,Current Protocols in Molecular BiologySuppl 9, Unit 3.3-3.32 (1987).
T. Taga et al., “Interleukin-6 Triggers the Association of its Receptor with a Possible Signal Transducer, gp130”,Cell 58:573-581 (1989).
S. Mizushima et al., “pEF-BOS, a Powerful Mammalian Expression Vector”,Nucleic Acids Research 18(17) (1990).
J.F. Bazan, “Structural Design and Molecular Evolution of a Cytokine Receptor Superfamily”,Proc. Natl. Acad. Sci. USA 87:6934-6938 (1990).
S.R. Paul et al., “Molecular Cloning of a cDNA Encoding Interleukin 11, a Stromal Cell-Derived Lymphopoietic and Hematopoietic Cytokine”,Proc. Natl. Acad. Sci. USA 87:7512-7516 (1990).
I. Kawashima et al., “Molecular Cloning of cDNA Encoding Adipogenesis Inhibitory Factor and Identity with Interleukin-11”,Febs Letters 283(2):199-202 (1991).
D.P. Gearing et al., “Homology of the p40 Subunit of Natural Killer Cell Stimulatory Factor (NKSF) with the Extracellular Domain of the Interleukin-6 Receptor”,Cell 66:9-10 (1991).
H. Baumann et al., “Interleukin-11 Regulates the Hepatic Expression of the Same Plasma Protein Genes as Interleukin-6”,The Journal of Biological Chemistry 266(30):20424-20427 (1991).
M. Musashi et al., “Synergistic Interactions between Interleukin-11 and Interleukin-4 in Support of Proliferation of Primitive Hematopoietic Progenitors of Mice”,Blood 78(6):1448-1451 (1991).
A.M. DeVos et al., “Human Growth Hormone and Extracellular Domain of its Receptor: Crystal Structure of the Complex”,Science 255:306-312 (1992).
D.M. Merberg et al., “Sequence Similarity between NKSF and the IL-6/G-CSF Family”,Immunology Today 13(2):77-78 (1992).
M.J. Layton et al., “A Major Binding Protein for Leukemia Inhibitory Factor in Normal Mouse Serum: Identification as a Soluble Form of the Cellular Receptor”,Proc. Natl. Acad. Sci. USA 89:8616-8620 (1992).
K.R. Schibler et al., “Effect of Interleukin-11 on Cycling Status and Clonogenic Maturation of Fetal and Adult Hematopoietic Progenitors”,Blood 80(4):900-903 (1992).
K. Tsuji et al., “Enhancement of Murine Hematopoiesis by Synergistic Interactions between Steel Factor (ligand for c-kit), Interleukin-11, and Other Early Acting Factors in Culture”,Blood 79(11):2855-2860 (1992).
S.A. Burstein et al., “Leukemia Inhibitory Factor and Interleukin-11 Promote Maturation of Murine and Human Megakaryocytes In Vitro”,Journal of Cellular Physiology 153:305-312 (1992).
Y-C Yang et al., “Interleukin-11 and its Receptor”,BioFactors 4(1):15-21 (1992).
M. Teramura et al., “Interleukin-11 Enhances Human Megakaryocytopoiesis In Vitro”,Blood 79(2):327-331 (1992).
Y. Yonemura et al., “Synergistic Effects of Interleukin 3 and Interleukin 11 on Murine Megakaryopoiesis in Serum-Free Culture”,Experimental Hematology 20:1011-1016 (1992).
D.C. Keller et al., “Interleukin-11 Inhibits Adipogenesis and Stimulates Myelopoiesis in Human Long-Term Marrow Cultures”,Blood 82(5):1428-1435 (1993).
G. Hangoc et al., “In Vivo Effects of Recombinant Interleukin-11 on Myelopoiesis in Mice”,Blood 81(4):965-972 (1993).
X.X. Du et al., “Interleukin-11: A Multifunctional Growth Factor Derived from the Hematopoietic Microenvironment”,Blood 83(8):2023-2030 (1994).
Y. Hirata et al., “ADP Ribosyl Cyclase Activity of a Novel Bone Marrow Stromal Cell Surface Molecule, BST-1”,Febs Letter 356:244-248 (1994).
N.C. Wrighton et al., “Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin”,Science 273:458-463 (1996).
D.J. Hilton et al., “Cloning and Characterization of a Binding Subunit of the Interleukin 13 Receptor that is also a Component of the Interleukin 4 Receptor”,Proc. Natl. Acad. Sci. USA 93:497-501 (1996).
S.F. Altschul et al., “Gapped BLAST and PSI-BLAST: a New Generation of Protein Database Search Programs”,Nucleic Acids Research 25(17):3389-3402 (1997).
S.E. Cwirla et al., “Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine”,Science 276:1696-1699 (1997).
Y. Shi et al., “Computational EST Database Analysis Identifies a Novel Member of Neuropoietic Cytokine Family”,Biochemical and Biophysical Research Communications 262(1):132-138 (1999).
Greg C. A. Elson, et al., “CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex”,Nature Neuroscience, 3(9): 867-872 (2000).
Bartlett Perry F.
Fabri Louis J.
Hasegawa Masakazu
Hilton Douglas J.
Jachno Kim Maree
Mertz Prema
Scully , Scott, Murphy & Presser, P.C.
Zenyth Operations Pty Ltd.
LandOfFree
Biologically active complex of NR6 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active complex of NR6 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active complex of NR6 and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3788120